
|
|
||||||
|
Medications
![]() ![]()
|
||||||
Cardiotoxicity and HerceptinAs with many monoclonal antibodies, Herceptin can increase the risk of congestive heart failure. One clinical study of cardiotoxicity and Herceptin showed that up to 16 percent of people had to stop taking the medication due to heart problems. Specifically, Herceptin increases problems in the left ventricle of the heart. This risk of heart problems was the highest in people taking Herceptin along with anthracyclines (chemotherapy medications).
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
|
||||||
|
||||||